Initial Antituberculous Regimen with Better Drug Penetration into Cerebrospinal Fluid Reduces Mortality in HIV Infected Patients with Tuberculous Meningitis: Data from an HIV Observational Cohort Study
Open Access
- 12 August 2013
- journal article
- research article
- Published by Wiley in Tuberculosis Research and Treatment
- Vol. 2013, 1-7
Abstract
Tuberculous meningitis (TM) is the deadliest form of tuberculosis. Nearly two-thirds of HIV infected patients with TM die, and most deaths occur within one month. Current treatment of TM involves the use of drugs with poor penetration into the cerebro-spinal fluid (CSF). In this study, we present the mortality before and after implementing a new antituberculous regimen (ATR) with a higher drug penetration in CSF than the standard ATR during the initial treatment of TM in an HIV cohort study. The new ATR included levofloxacin, ethionamide, pyrazinamide, and a double dose of rifampicin and isoniazid and was given for a median of 7 days (interquartile range 6–9). The new ATR was associated with an absolute 21.5% (95% confidence interval (CI), 7.3–35.7) reduction in mortality at 12 months. In multivariable analysis, independent factors associated with mortality were the use of the standard ATR versus the new ATR (hazard ratio 2.05; 95% CI, 1.2–3.5), not being on antiretroviral therapy, low CD4 lymphocyte counts, and low serum albumin levels. Our findings suggest that an intensified initial ATR, which likely results in higher concentrations of active drugs in CSF, has a beneficial effect on the survival of HIV-related TM.Keywords
This publication has 22 references indexed in Scilit:
- Association of Serum Albumin Concentration With Mortality, Morbidity, CD4 T-cell Reconstitution Among Tanzanians Initiating Antiretroviral TherapyThe Journal of Infectious Diseases, 2013
- Natural History and Factors Associated with Early and Delayed Mortality in HIV-Infected Patients Treated of Tuberculosis under Directly Observed Treatment Short-Course Strategy: A Prospective Cohort Study in IndiaInterdisciplinary Perspectives on Infectious Diseases, 2012
- Treatment outcome, mortality and their predictors among HIV-associated tuberculosis patientsInternational Journal of STD & AIDS, 2012
- Factors Associated with Late Presentation of HIV and Estimation of Antiretroviral Treatment Need according to CD4 Lymphocyte Count in a Resource-Limited Setting: Data from an HIV Cohort Study in IndiaInterdisciplinary Perspectives on Infectious Diseases, 2012
- Tuberculous Meningitis: Diagnosis and Treatment OverviewTuberculosis Research and Treatment, 2011
- Randomized Pharmacokinetic and Pharmacodynamic Comparison of Fluoroquinolones for Tuberculous MeningitisAntimicrobial Agents and Chemotherapy, 2011
- Intensified treatment with high dose Rifampicin and Levofloxacin compared to standard treatment for adult patients with Tuberculous Meningitis (TBM-IT): protocol for a randomized controlled trialTrials, 2011
- Neurologic Manifestations of Paradoxical Tuberculosis‐Associated Immune Reconstitution Inflammatory Syndrome: A Case SeriesClinical Infectious Diseases, 2009
- Clinical and Microbiological Features of HIV-Associated Tuberculous Meningitis in Vietnamese AdultsPLOS ONE, 2008
- Tuberculous meningitis in HIV-infected patients: drug susceptibility and clinical outcomeAIDS, 2007